Skip to content

Tetra CO2 with CoolPeel® is Making CO2 Laser Resurfacing More Accessible for Patients in Canada

MELVILLE, N.Y. (PRWEB) | September 14, 2021

CO2 lasers have long been regarded as an aesthetic gold-standard for treating aging skin and has become synonymous with real improvement in wrinkles, age-spots and skin texture. However, these results have historically come at the expense of days, even weeks, of downtime thus limiting the willingness of aesthetic patients to undergo CO2 treatments. Attitudes towards CO2 shifted in 2019 when Tetra CO2 and the exclusive CoolPeel® treatment was introduced in the U.S marketplace. Now approved by Health Canada, the technology is poised to drive new demand amongst practitioners and patients.

The CoolPeel is a highly superficial CO2 laser treatment that reduces the appearance of fine lines, sun damage and pores with virtually no downtime. Cartessa Aesthetics, the exclusive distributor of the Tetra CO2 in the U.S. and Canada, developed this game changing protocol in conjunction with its manufacturing partner, DEKA. The CoolPeel leverages the Tetra’s exclusive H-pulse – a high-peak power, short pulse that delivers a fractional ablative treatment without thermal damage to the surrounding tissue. No thermal damage means that downtime is highly controlled and minimized while impressive superficial, skin-resurfacing results are delivered. Only the Tetra CO2 has this unique pulse control to customize treatments from a fully ablative procedure to the low-downtime CoolPeel.

“Our goal at Cartessa is to not only select the best aesthetic technologies available but then translate advancements into new revenue streams for our customers,” shared Gabe Lubin, founder and CEO of Cartessa. “DEKA is regarded as the best CO2 laser manufacturer globally. We worked closely with them to hone-in on Tetra’s unique capabilities and what new treatments it can deliver to meet the needs of today’s aesthetic patients. If the popularity in the US is any indication, we expect our Canadian customers will be highly profitable with it.”

Since launching in the U.S., CoolPeel has gained a lot of traction with practices and patients, from social media to experts in the aesthetic field. Dr. Emil Tanghetti, Dermatologist, highlights, “The scanner on the Tetra unit is very sophisticated, and after the procedure, most patients can go about their business with a natural appearance. You can treat aggressively and non-aggressively which makes the Tetra a great platform.”

Cartessa is excited to now bring this advanced technology to Canada. Cartessa’s unique approach to selecting, distributing and supporting aesthetic technologies has made it one of the fastest growing companies in the US market – and their early Canadian customers are benefiting from the partnership. “Jeunesse Cosmetic Clinic has been working with the leaders in the laser industry for many years. Last year, we started working with Cartessa Aesthetics when they entered the Canadian market. Even with COVID setbacks, they have been a great partner with premium aesthetic devices and marketing support. We are thrilled that we now have Health Canada approval of Tetra CO2 CoolPeel. We’ve watched the success and amazing results patients have in the U.S. with CoolPeel and are excited Canada will now have access to this unique technology,” praises David Ben, CEO of Jeunesse Cosmedical in Vaughan, Ontario.

CoolPeel® is a registered trademark to Cartessa Aesthetics. Canadian practitioners interested in learning more about the Tetra and CoolPeel can reach out to a Cartessa agent or visit their website to learn more. Patients can also visit for more information.

About Cartessa Aesthetics
Cartessa Aesthetics, LLC sources leading aesthetic medical devices for distribution to dermatologists, plastic surgeons, cosmetic physicians and medical spas in the U.S. and Canada.

Cartessa selects the most cutting-edge technologies that offer clinically proven efficacy, patient safety, and the best possible investment for patients and professionals. All products within Cartessa’s portfolio are FDA- and/or Health Canada-cleared.

Contact Us